Study of Azacitidine and Durvalumab in Advanced Solid Tumors

Clinical trial NCT02811497 · COMPLETED

Trial details

NCT number: NCT02811497
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Microsatellite Stable Colorectal Carcinoma Platinum Resistant Epithelial Ovarian Cancer Type II Estrogen Receptor Positive and HER2 Negative Breast Cancer

Start date: 2016-09-01
Primary completion: 2018-11-08
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.